Jena Leisher
Nurse Practitioner · Lancaster, PANPI 1831737519
Payments from drug & device makers
Across 256 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$989
- Alkermes, Inc.$851
- Otsuka America Pharmaceutical, Inc.$735
- Neurocrine Biosciences, Inc.$637
- Supernus Pharmaceuticals, Inc.$402
- plus $1K from 9 others
What the payments were for
- Food & beverage$5,87399%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 54 | $1,078 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $989 |
| Alkermes, Inc. | 30 | $851 |
| Otsuka America Pharmaceutical, Inc. | 31 | $735 |
| Neurocrine Biosciences, Inc. | 29 | $637 |
| Supernus Pharmaceuticals, Inc. | 17 | $402 |
| Axsome Therapeutics, Inc. | 14 | $317 |
| Lundbeck LLC | 16 | $270 |
| Johnson & Johnson | 10 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $159 |
| Sunovion Pharmaceuticals Inc. | 6 | $131 |
| Ironshore Pharmaceuticals Inc. | 5 | $79 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,341
- CAPLYTA$361
- VRAYLAR$350
- ABILIFY ASIMTUFII$250
- ABILIFY MAINTENA$250
- QELBREE$200
- INGREZZA$125
How this compares
$5,930 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 12 | $4,859 |
| Duloxetine Hcl | 24 | $607 |
| Bupropion XlBupropion Hcl | 29 | $441 |
| Olanzapine | 13 | $395 |
| Ziprasidone Hcl | 14 | $372 |
| Trazodone Hcl | 28 | $369 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $321 |
| Mirtazapine | 16 | $208 |
| Quetiapine Fumarate | 16 | $207 |
| Aripiprazole | 20 | $204 |
| Escitalopram Oxalate | 23 | $121 |
| Sertraline Hcl | 33 | $109 |
| Lamotrigine | 15 | $63 |
| Risperidone | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Lancaster
- Emily FoxLancaster$9K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.